📰 Merck Sharp News
Page 103 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
December 7, 2021
DBMR has added a new report titled Cheilitis Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. The high-quality Cheilitis Market research report is a resource for getting current as well as upcoming technical and...
December 7, 2021
Pharmac has been accused of institutional racism for funding drugs for melanoma, but not lung cancer – a disease that kills twice as many Māori and non-Māori.
December 6, 2021
KUALA LUMPUR: The government will review the procurement of antivirals to treat Covid-19 patients following the emergence of new drugs for this purpose, says Deputy Health Minister Datuk Dr Noor Azmi Ghazali.
December 6, 2021
This video series and advertorial are fully funded and developed by MSD. Click the following links for prescribing information for Keytruda®
December 6, 2021
/PRNewswire/ -- Carisma Therapeutics., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced...
December 6, 2021
The Ministry of Health (MOH) will readjust the purchase of the antiviral drug Molnupiravir as well as the need for the purchase of drugs for Covid-19 treatment based on the RM172 million allocation provided by the government
December 5, 2021
Health Secretary Sajid Javid is reportedly set to launch a national pilot of the Molnupiravir antiviral pill, also known as Lagevrio, in a bid to protect the vulnerable from Omicron.
December 5, 2021
An antiviral pill to treat Covid-19 could be rolled out to patients before Christmas in a bid to protect the most vulnerable.
December 5, 2021
An antiviral pill to treat Covid-19 could be rolled out to patients before Christmas in a bid to protect the most vulnerable.
December 5, 2021
An antiviral pill to treat Covid-19 could be rolled out to patients before Christmas in a bid to protect the most vulnerable.